301 Inhibition of lysine-specific histone demethylase 1A (KDM1A/LSD1) attenuates DNA double strand break repair and enhances efficacy of temozolomide in glioblastoma

por Alejo, Salvador, Palacios, Bridgitte, Venkata, Prabhakar Pitta, He, Yi, Li, Wenjing, Johnson, Jessica, Jayamohan, Sridharan, Vadlamudi, Ratna, Sareddy, Gangadhara
Publicado 2023

Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways

por Zhou, Mei, Sareddy, Gangadhara R., Li, Mengxing, Liu, Jinyou, Luo, Yiliao, Venkata, Prabhakar Pitta, Viswanadhapalli, Suryavathi, Tekmal, Rajeshwar R., Brenner, Andrew, Vadlamudi, Ratna K.
Publicado 2019

Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist

por He, Yi, Alejo, Salvador, Venkata, Prabhakar Pitta, Johnson, Jessica D., Loeffel, Ilanna, Pratap, Uday P., Zou, Yi, Lai, Zhao, Tekmal, Rajeshwar R., Kost, Edward R., Sareddy, Gangadhara R.
Publicado 2022

PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling

por Sareddy, Gangadhara R, Pratap, Uday P, Viswanadhapalli, Suryavathi, Venkata, Prabhakar Pitta, Nair, Binoj C, Krishnan, Samaya Rajeshwari, Zheng, Siyuan, Gilbert, Andrea R, Brenner, Andrew J, Brann, Darrell W, Vadlamudi, Ratna K
Publicado 2019

Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma

por Pratap, Uday P, Sareddy, Gangadhara R, Liu, Zexuan, Venkata, Prabhakar Pitta, Liu, Junhao, Tang, Weiwei, Altwegg, Kristin A, Ebrahimi, Behnam, Li, Xiaonan, Tekmal, Rajeshwar R, Viswanadhapalli, Suryavathi, McHardy, Stanton, Brenner, Andrew J, Vadlamudi, Ratna K
Publicado 2021